Daniela Bischof, PhD
Assistant Professor of Clinical Medical & Molecular Genetics
- Phone
- (317) 278-6518
- Address
-
R3 C602D
MMGE
IN
Indianapolis, IN
Bio
Dr. Bischof has been a member of Medical and Molecular Genetics since 2006, and joined the Indiana University Vector Production Facility (IUVPF) in 2007. The IUVPF is a core laboratory within the Indiana University School of Medicine and is dedicated to the development, production and testing of gene therapy technology (lentiviruses and retroviruses). In addition to production services, the IUVPF offers a wide variety of routine and specialized assays important in safety testing and certifying both clinical and non-clinical grade vectors.
Key Publications
Bischof D (2022). Keeping things clean: The secret to successful vector production for gene therapy. Research Features 143: 58-61 (https://cdn.researchfeatures.com/3d_issues/RF143/index.html?_ga=2.200353963.484168336.1664224461-7222072.1651769519).
Bischof D and Cornetta (2022). Cell Therapy: cGMP Facilities and Manufacturing – Indiana University Vector Production Facility (IUVPF). ISBN-13: 978-3030755355.
Bischof D and Hopewell E (2020). Vector production in academia: obstacles and opportunities. Cell & Gene Therapy Insights; 6(3), 267–273 (DOI: 10.18609/cgti.2020.036). (Online article).
| Year | Degree | Institution |
|---|---|---|
| 1997 | PhD | University of the Witwatersrand |
| 1991 | BSC | University of the Witwatersrand |
| 1990 | BSC | University of the Witwatersrand |
Dr. Bischof current serves as the director of the Indiana University Vector Production Facility (IUVPF), a core laboratory within the School of Medicine that is dedicated to the production and development of gene therapy technology.
Their research manufactures retroviral and lentiviral vectors for both pre-clinical (IND enabling) studies and FDA Phase I/II human gene therapy clinical trials.
Desc: Trustees' Teaching Award
Scope: University
Date: 2025-04-01